Apple Loses Bid to Overturn $634 Million Masimo Patent Verdict
Apple Faces Major Setback in Masimo Patent Battle
In a significant legal development for the smartwatch industry, Apple has lost its bid to overturn a staggering $634 million patent verdict in its ongoing dispute with medical technology company Masimo. The ruling, confirmed in July 2026, represents one of the largest patent infringement awards in wearable technology history.
According to 9to5Mac, Apple's requests to both overturn the verdict and secure a new trial were denied by the court, marking a decisive victory for Masimo in the long-running intellectual property battle.
Key Details of the Patent Dispute
| Case Detail | Information |
|---|---|
| Verdict Amount | $634 million |
| Plaintiff | Masimo Corporation |
| Defendant | Apple Inc. |
| Technology in Question | Wearable health monitoring sensors |
| Verdict Status | Upheld (July 2026) |
Impact on Wearable Health Technology
The Masimo patent case centers on pulse oximetry and other health monitoring technologies used in the Apple Watch. Masimo has long been a leader in non-invasive patient monitoring technologies, and the company alleged that Apple incorporated its patented innovations into the Apple Watch without proper licensing.
This verdict has significant implications for the wearable health technology market, potentially affecting how smartwatch manufacturers approach sensor technology development and intellectual property compliance.
Industry Implications
- Patent Portfolio Value: The ruling reinforces the importance of robust patent portfolios in the wearable health space
- Innovation Risk: Tech companies face increased scrutiny when developing health monitoring features
- Licensing Importance: The case highlights the critical need for proper licensing agreements in medical technology
- Competitive Landscape: Other smartwatch makers may need to reassess their health sensor implementations
Frequently Asked Questions
What patents were at issue in the Apple vs. Masimo case?
The dispute centered on Masimo's patented pulse oximetry and non-invasive blood constituent monitoring technologies, which are used in wearable health devices like smartwatches.
How does this verdict affect Apple Watch users?
While the verdict is a significant financial blow to Apple, it is unlikely to directly affect current Apple Watch users. However, future Apple Watch models may feature redesigned health sensors to avoid further patent infringement issues.
What happens next in the legal battle?
With the court denying Apple's motion to overturn the verdict and request a new trial, Apple may choose to pursue further appeals or negotiate a licensing agreement with Masimo.
According to 9to5Mac. Learn more about how to choose the right smartwatch for your needs.